GB Sciences, Inc. (OTCQB: GBLX) is a plant-inspired research and biopharmaceutical drug development company whose goal is to create patented formulations of plant-based, optimized therapeutic mixtures that target a variety of medical conditions.
Looking for a particular GB Sciences, Inc employee's phone or email?
The GB Sciences, Inc annual revenue was $23 million in 2026.
John Poss is the CFO of GB Sciences, Inc.
15 people are employed at GB Sciences, Inc.
GB Sciences, Inc is based in Las Vegas, Nevada.
The NAICS codes for GB Sciences, Inc are [32541, 541, 3254, 54, 32, 325].
The SIC codes for GB Sciences, Inc are [28, 283, 2834].